MiR-3918 Inhibits Tumorigenesis of Glioma via Targeting EGFR to Regulate PI3K/AKT and ERK Pathways
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s12031-021-01952-1.pdf
Reference26 articles.
1. Acunzo M, Romano G, Wernicke D, Croce CM (2015) MicroRNA and cancer–a brief overview. Adv Biol Regul 57:1–9
2. Alzahrani AS (2019) PI3K/Akt/mTOR inhibitors in cancer: at the bench and bedside. Semin Cancer Biol 59:125–132
3. Biswas S (2018) MicroRNAs as therapeutic agents: the future of the battle against cancer. Curr Top Med Chem 18(30):2544–2554
4. Colquhoun A (2017) Cell biology-metabolic crosstalk in glioma. Int J Biochem Cell Biol 89:171–181
5. Chen H, Zhou L, Wu X et al (2016) The PI3K/AKT pathway in the pathogenesis of prostate cancer. Front Biosci (Landmark edition) 21:1084–1091
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Mir-338-3p targeting THBS1 attenuates glioma progression by inhibiting the PI3K/Akt pathway;Biology Direct;2024-01-24
2. BTC as a Novel Biomarker Contributing to EMT via the PI3K-AKT Pathway in OSCC;Frontiers in Genetics;2022-07-01
3. Identification of Serum miRNAs as Effective Diagnostic Biomarkers for Distinguishing Primary Central Nervous System Lymphoma from Glioma;Journal of Immunology Research;2022-04-20
4. Long noncoding RNA CCDC183-AS1 depletion represses breast cancer cell proliferation, colony formation, and motility by sponging microRNA-3918;Oncology Research;2021
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3